Skip to main content

Table 2 Clinical and genetic data for the 9 successfully amplified cases with PACC

From: Molecular genetic studies on EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and DDR2 in primary pulmonary adenoid cystic carcinoma

No.

Age (y)

Gender

Location

Genetic mutation

EGFR

KRAS

BRAF

PIK3CA

ALK

DDR2

PDGFRA

1

38

M

Trachea (upper 1/3)

-

-

-

-

-

-

-

2

56

F

Trachea (upper 1/3)

-

-

-

-

-

-

-

3

35

F

Trachea (lower 1/3)

-

-

-

-

-

-

-

4

60

F

Trachea (lower 1/3)

-

-

-

-

-

-

-

5

51

F

Trachea (lower 1/3)

-

-

-

-

-

-

-

6

57

F

Trachea (upper 1/3)

-

-

-

-

-

-

-

7

62

F

Trachea (middle 1/3)

-

-

-

-

-

-

-

8

74

F

Trachea (upper 1/3)

-

-

-

-

-

-

-

9

46

F

Trachea (lower 1/3)

-

-

-

-

-

-

-